Patents by Inventor Roger Olsson

Roger Olsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, salts thereof and methods for treatment of diseases
    Patent number: 12139477
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: November 12, 2024
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Ethan S. Burstein, Roger Olsson, Björn Gustav Borgström, Karl Erik Jansson, Niklas Patrik Sköld, Henrik Von Wachenfeldt, Larisa Yudina Wahlström
  • Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c
    Patent number: 11840515
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: December 12, 2023
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20220298151
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Application
    Filed: May 27, 2022
    Publication date: September 22, 2022
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Björn Gustav BORGSTRÖM, Karl Erik JANSSON, Niklas Patrik SKÖLD, Henrik VON WACHENFELDT, Larisa Yudina WAHLSTRÖM
  • Compounds, salts thereof and methods for treatment of diseases
    Patent number: 11440884
    Abstract: The present disclosure relates to compounds according to Formulae (I), (II) and (VIII), useful for treating diseases.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 13, 2022
    Assignee: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. Burstein, Roger Olsson, Karl Erik Jansson, Niklas Patrik Sköld, Larisa Yudina Wahlström, Björn Gustav Borgström, Henrik Von Wachenfeldt, Magnus Gustav Wilhelm Bergner
  • Compounds, salts thereof and methods for treatment of diseases
    Patent number: 11345693
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: May 31, 2022
    Assignee: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. Burstein, Roger Olsson, Björn Gustav Borgström, Karl Erik Jansson, Niklas Patrik Sköld, Henrik Von Wachenfeldt, Larisa Yudina Wahlström
  • User interface for video call with content sharing
    Patent number: 11272139
    Abstract: A user interface and method for establishing a video call to share data associated with a software application executed on an electronic device. One or more first selectable user interface objects representing software applications installed on the electronic device, one or more second selectable UI objects representing contacts of a user of the electronic device and a third selectable UI object related to executing a video call are displayed on the touch-sensitive display. A selection of one of the first selectable UI objects and a selection of the second selectable UI objects are determined. Upon detecting a touch input selecting of the third selectable UI object, the software application selected by the determining is executed, and a video call is established between the first electronic device and a second electronic device of the contact selected by the determining in order to exchange data associated with the software application.
    Type: Grant
    Filed: September 29, 2019
    Date of Patent: March 8, 2022
    Assignee: Sony Group Corporation
    Inventors: Miro Stojakovic, Jacob Fyge, Bo Do, Daniel Johansson, Maximiliano Gabriel, Roger Olsson
  • METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C
    Publication number: 20220024871
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Application
    Filed: March 16, 2021
    Publication date: January 27, 2022
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages
    Patent number: 11033545
    Abstract: The present disclosure relates to the use of negative allosteric modulators (NAMs) of the metabotropic glutamate receptor 5 (mGluR5) in the treatment of a mature brain damage, such as damage after stroke.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: June 15, 2021
    Assignee: Sinntaxis AB
    Inventors: Tadeusz Wieloch, Carin Sjölund, Kerstin Beirup, Karsten Ruscher, Roger Olsson
  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20210122713
    Abstract: The present disclosure relates to compounds according to Formulae (I), (II) and (VIII), useful for treating diseases.
    Type: Application
    Filed: August 20, 2018
    Publication date: April 29, 2021
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Karl Erik JANSSON, Niklas Patrik SKÖLD, Larisa Yudina WAHLSTRÖM, Björn Gustav BORGSTRÖM, Henrik VON WACHENFELDT, Magnus Gustav Wilhelm BERGNER
  • Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form
    Patent number: 10981870
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: April 20, 2021
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C
    Patent number: 10981871
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: April 20, 2021
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20200270239
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Björn Gustav BORGSTRÖM, Karl Erik JANSSON, Niklas Patrik SKÖLD, Henrik VON WACHENFELDT, Larisa Yudina WAHLSTRÖM
  • METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM
    Publication number: 20200181087
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Application
    Filed: February 10, 2020
    Publication date: June 11, 2020
    Applicant: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM
    Publication number: 20200165202
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N,-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —OR, or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-4 alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N- methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobemzyl)-N-(1-methylpiperidin-4-yl)-N?,-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 28, 2020
    Applicant: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • USER INTERFACE FOR VIDEO CALL WITH CONTENT SHARING
    Publication number: 20200128209
    Abstract: A user interface and method for establishing a video call to share data associated with a software application executed on an electronic device. One or more first selectable user interface objects representing software applications installed on the electronic device, one or more second selectable UI objects representing contacts of a user of the electronic device and a third selectable UI object related to executing a video call are displayed on the touch-sensitive display. A selection of one of the first selectable UI objects and a selection of the second selectable UI objects are determined. Upon detecting a touch input selecting of the third selectable UI object, the software application selected by the determining is executed, and a video call is established between the first electronic device and a second electronic device of the contact selected by the determining in order to exchange data associated with the software application.
    Type: Application
    Filed: September 29, 2019
    Publication date: April 23, 2020
    Inventors: Miro Stojakovic, Jacob Fyge, Bo Do, Daniel Johansson, Maximiliano Gabriel, Roger Olsson
  • Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C
    Patent number: 10597363
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: March 24, 2020
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • NEGATIVE ALLOSTERIC MODULATORS OF MGLUR5 FOR USE IN THE TREATMENT OF MATURE BRAIN DAMAGES
    Publication number: 20190365753
    Abstract: The present disclosure relates to the use of negative allosteric modulators (NAMs) of the metabotropic glutamate receptor 5 (mGluR5) in the treatment of a mature brain damage, such as damage after stroke.
    Type: Application
    Filed: March 30, 2016
    Publication date: December 5, 2019
    Inventors: Tadeusz Wieloch, Carin Sjölund, Kerstin Beirup, Karsten Ruscher, Roger Olsson
  • METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM
    Publication number: 20190047955
    Abstract: Disclosed herein are methods for obtaining N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin) comprising the step of contacting an intermediate according to Formula (A) or a salt thereof, with an intermediate Formula B, or a salt thereof, to produce pimavanserin or a salt thereof wherein Y is —ORi or —NR2aR2b; R3 is hydrogen or substituted or unsubstituted heteroalicyclyl, R4 is substituted or unsubstituted aralkyl; X is —OR22 or —NR23R24; (wherein R22 is hydrogen or substituted or unsubstituted C1-6alkyl and one of R23 and R24 is hydrogen and the other is hydrogen or N-methylpiperidin-4-yl); and R21 is —OCH2CH(CH3)2 or F; Also disclosed herein is the tartrate salt of N-(4-fluoroben-zyl)-N-(1-methylpiperidin-4-yl)-N?-(4-(2-methylpropyloxy)phenylmethyl) carbamide and methods for obtaining the salt.
    Type: Application
    Filed: July 19, 2016
    Publication date: February 14, 2019
    Inventors: Marlon Carlos, Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Philipp Boudier, Beat T. Weber
  • Muscarinic agonists
    Patent number: 9670209
    Abstract: Compounds of formula (I) and methods are provided for the treatment of disease or conditions in which modification of cholinergic, especially muscarinic receptor activity, has a beneficial effect.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 6, 2017
    Assignees: ACADIA PHARMACEUTICALS INC., ALLERGAN, INC.
    Inventors: Ethan S. Burstein, Jorgen Eskildsen, Roger Olsson
  • Depth or disparity map upscaling
    Patent number: 9525858
    Abstract: Method and arrangement for increasing the resolution of a depth or disparity map related to multi view video. The method comprises deriving a high resolution depth map based on a low resolution depth map and a masked texture image edge map. The masked texture image edge map comprises information on edges in a high resolution texture image, which edges have a correspondence in the low resolution depth map. The texture image and the depth map are associated with the same frame.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: December 20, 2016
    Assignee: TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
    Inventors: Sebastian Schwarz, Ivana Girdzijauskas, Roger Olsson, Mårten Sjöström